U.S. Air Force SBIR/STTR Program
U.S. Air Force SBIR/STTR Program
Defense Threat Reduc0on Agency (DTRA) SBIR • POC/Title and or Ins0tute: Mark Flohr, Program Manager, DTRA SBIR. Mark.Flohr@dtra.mil • Mission/interest -‐ Safeguard the United States and its allies from Global WMD threats by integraEng, synchronizing, and providing experEse, technologies, and capabiliEes addressing warﬁghter needs. • Uniqueness -‐ DTRA SBIR is focused solely on CBRNE and combat support. Our S&T areas include Nuclear Eﬀects and Survivability, Enhanced Explosives & ConvenEonal Weapons Eﬀects, CBR DetecEon, ProtecEon, and Modeling & SimulaEon. • Budget -‐ Annual SBIR ~$7.0M • Topics -‐ Average six topics on the XX.3 solicitaEon • Awards (Amt and Dollar Range Average eight Phase I’s up to $150K each and ﬁve Phase II’s per year up to $1.0M each. • Contract vs Grant -‐ Contracts • Solicita0on (Pre-‐Solicita0on/Open/Close) – 21 Aug 14/22 Sep 14/22 Oct 14
Environmental Protec/on Agency SBIR Program • POC/Title and or Ins/tute/Website: www.epa.gov/ncer/sbir – April Richards, Program Manager, EPA SBIR Program • Mission/interest -‐ Support the development and commercializaBon of environmental technologies that help EPA meet its mission of protecBng human health and the environment. • Uniqueness -‐ Small program with focus on one-‐on-‐one relaBonships with companies to help them commercialize and have posiBve environmental impact. • Budget -‐ Annual SBIR ~$5M • Topics -‐ Priority topic areas include: water, air, green manufacturing, waste and homeland security. • Awards-‐ Average 25 Phase I’s up to $100K each and 10 Phase II’s per year up to $300,000. • Contract vs Grant -‐ Contracts • Solicita/ons (Open/Close) – One annual solicitaBon; typically opens in spring. • Commercializa/on Assistance -‐ EPA oﬀers commercializaBon assistance to all of its Phase I and Phase II awardees. Phase II companies are eligible for a “commercializaBon opBon ‐ a supplement of up to $100,000 to match third party investment.
www.acq.osd.mil/osbp/sbir • Program Manager: Dr. Douglas Deason, Director Advanced Research MDA Phone: (256) 955-2020 • Website: http://www.mda.mil/business/SBIR_STTR_programs.htm l • Mission: To promote innovative technology development through the SBIR/STTR program with relevance to the Ballistic Missile Defense System (BMDS) and commercial applications; and, to provide technology transition assistance. • Uniqueness: MDA SBIR/STTR promotes “technology pull”: more than 90 percent of topics come from system program elements. MDA determines success by the SBIR/STTR firm obtaining endorsement from an MDA system to mature and insert technology. • Annual Budget: Annual SBIR + STTR budget ~$75M • Average Topics per Year: MDA averages 30 SBIR and 10 STTR topics per year • Awards (Total and Dollar Amount): MDA averages 120 Phase I and 50 Phase II awards per year • Technology of Interest: Lightweight Materials, Data Processing Algorithms, Models and Simulations, Optics, Radar, Rocket Propulsion, Manufacturing Efficiency, and Energy Efficiency • In which Solicitations Do You Participate?: SBIR 14.2 and STTR 14.B • Commercialization Assistance : MDA offers the Technology Applications Program (TAP) through the National Technology Transfer Center (NTTC). ( www.mdatechnology.net ) The TAP provides commercialization assistance to MDA SBIR/STTR-funded companies • Twitter Handle: N/A Facebook Page: N/A Do You Host Webinars?: No Approved for Public Release 14-MDA-7777 (14 April 14)
NASA SBIR/STTR Programs • POC/Title and or Ins9tute/Website: Program Execu-ve for NASA SBIR/STTR, Richard B. Leshner, PhD hAp://sbir.nasa.gov • Mission/interest -‐ Technology that addresses future mission needs in NASA’s Mission Directorates – Science, Aeronau-cs Research, Human Explora-on and Opera-ons, and Space Technology • Uniqueness -‐ The SBIR/STTR program supports both “push” and “pull” technology development – some-mes ar-cula-ng NASA needs for technology development and iden-fying certain performance criteria, other -mes describing a future desired capability and seeking proposals with innova-ve ideas to sa-sfy that need. Topics are generated by experts at NASA Centers who plan for and execute NASA tech demo ﬂights and opera-onal missions. • Award Budget -‐ Annual SBIR + STTR budget ~$160M • Topics -‐ Average 75 SBIR and 20 STTR Topics per year • Awards (Amt and Dollar Range Average 300 Phase I’s at $125K each, and 90-‐110 Phase II’s per year ranging from $750K to $1.5M. • Contract vs Grant -‐ Contracts • Solicita9ons (Open/Close) – Mid November 2014 – Late January 2015 • Commercializa9on Assistance -‐ NASA oﬀers op-ons to expand projects beyond Phase 2 from 6-‐24 months: if companies can ﬁnd non-‐NASA SBIR/STTR investments to enhance their SBIR/STTR projects beyond what is accomplished in Phase 2, the NASA SBIR/STTR program will match those investments (within certain limits).
Department of the Navy (DON) SBIR/STTR Programs NAVSEA • POC/Title and Website: Dean Putnam, SBIR Program Manager • Mission/interest -‐ Technology that addresses Naval warﬁghter needs. We invest in small business and help them to transiDon that technology into a DON or DoD weapons system, program or plaForm. • Uniqueness -‐ NAVSEA SBIR/STTR promotes “technology pull”: >90% of Topics come from ship, submarine, carrier and weapon system acquisiDon program oﬃces. Our success is the SBIR/STTR ﬁrm obtaining Phase III funding from that program to mature, procure and deploy innovaDons. • Budget -‐ Annual NAVSEA SBIR + STTR budget = ~$75M • Topics -‐ SBIR and STTR Topics vary each year -‐ 75 are anDcipated in FY 15.1 RFP • Awards (Amt and Dollar Range Average 125 Phase I’s up to $150K each and 70 Phase II’s per year range from $350K to $1.5M. • Contract vs Grant -‐ Contracts • SolicitaNons (Open/Close) – 16 Nov/16 Jan, 25 Jan/27 Mar, 24 Apr/26 Jun, 26 Jul/25 Sep • CommercializaNon Assistance -‐ NAVSEA parDcipates in the DON 11-‐month TransiDon Assistance Program for all Phase II awardees with Navy Opportunity Forum annually. NAVSEA has SBIR/STTR TransiDon Managers and support staﬀ within each SYSCOM and Program ExecuDve Oﬃce to support ﬁrm and Naval needs.
http://sbir.cancer.gov Benefits of the SBIR/STTR Programs STTR: Small Business Technology Transfer CROSSING THE VALLEY OF DEATH NCI SBIR Phase IIB Bridge Award Phase III COMMERCIALIZATION Phase II DEVELOPMENT Phase I FEASIBILITY • Commercialization stage • Use of non-SBIR/STTR funds • Research & Development • Commercialization plan required • $1M over 2 years; max $1.5M* • Technology validation & clinical translation • Follow-on funding for SBIR Phase II awardees • Expectation that applicants will secure substantial 3rd-party investor funds • $1M per year over 3 years SBIR/STTR Program Goals • Stimulate technological innovation • Meet Federal R&D needs • Foster & encourage participation in innovation & entrepreneurship by socially & economically disadvantaged persons • Increase private-sector commercialization of innovations derived from Federal R&D funding • Funding is non-dilutive & doesn’t impact company stock • Awards are not loans; no repayment is required • Intellectual property rights are retained by the small business • Awards provide company recognition, verification, and visibility • Projects are vetted through NIH’s rigorous scientific peer review • Can be used as leverage to attract additional funding SBIR: Small Business Innovation Research • Set-aside program to fund small business early stage R&D • For small business concerns (SBC) that are organized as for-profit US- based businesses with fewer than 500 employees • SBC must do at least 2/3 of R&D work in Phase I, at least 1/2 in Phase II • PI must be greater than 50% employed by SBC • Basic SBC eligibility same as SBIR • Formal cooperative R&D effort with a US research institution • SBC must do minimum 40% of work; research institution must do minimum 30% of work • PI may be primarily employed by either SBC or research institution FY14 SBIR/STTR Funding ~$757M at NIH ~$119M at NCI NCI SBIR Development Center NEW Direct- to-Phase II Fast-Track Application Combined Phase I & II • Proof-of-Concept study • $150,000 over 6 mo (SBIR), 1 year (STTR); max $225,000*
NCIsbir@mail.nih.gov 240.276.5300 Twitter: @NCIsbir http://sbir.cancer.gov NCI SBIR Phase IIB Bridge Award http://sbir.cancer.gov/funding/phase2bridgeaward.a sp • Up to $1M/year for up to 3 years following a Ph II award • Open to all SBIR or STTR Phase II awardees working on: cancer therapeutics, imaging technologies, diagnostics • Competitive preference & funding priority to applicants raising substantial third-party funds (i.e. ≥ 1:1 match) Recent Changes to the SBIR/STTR Programs Percentage of extramural NIH funding reserved is increasing for SBIR (2.8% FY14, 2.9% FY15) & STTR (0.40% FY14-FY15) • $5000 Technical Assistance award requests, open to SBIR & STTR • Limits on Award Sizes: $225,000 (Ph I), $1.5M (Ph II) *Waivers available for FY15 projects in specific topic areas • Small businesses majority owned by multiple VCOCs, hedge funds, or private equity firms are now eligible to apply for NIH SBIR funding • NEW – Direct-to-Phase II Pilot program announced http://bit.ly/NIHD2P2 • NEW – SBIR Ph I awardees can apply for STTR Ph II and vice versa For the Latest on NIH Implementation: http://go.usa.gov/gubA What We’re Funding Therapeutics 36% In Vitro Diagnostics 18% Devices for Cancer Therapy 9% Imaging 16% Health IT & Software Tools 8% Tools for Basic Research 13% Grant Funding Opportunities Omnibus Solicitation Applications due: Apr 5, Aug 5, Dec 5 • Investigator-initiated projects accepted in a broad range of areas supporting the mission of NCI Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (SBIR-IMAT, PAR-13-327) Applications due November 4 & May 28; through 2016 http://sbir.cancer.gov/funding/technology/ • For next-generation molecular and cellular analytical technologies for cancer detection and/or characterization Innovative Health IT for Broad Adoption by Healthcare Systems and Consumers (PA-12-196) Applications due: April 5, August 5, December 5 through 2014 Phase II or Fast-Track Applications Only http://sbir.cancer.gov/resource/hit/ • For development & dissemination of evidence-based health IT products Development of Highly Innovative Tools and Technology for Analysis of Single Cells (PA-13-140) Applications due: April 5, August 5, December 5 through 2015 http://commonfund.nih.gov/Singlecell/ • For next-generation tools that distinguish heterogeneous states among individual cells Applications due April 21, 2014 Contract Solicitation http://sbir.cancer.gov/funding/contracts • Research areas of high priority to NCI with set- aside funds & milestone-driven deliverables Recent topics include: • Therapeutic agents targeting Cancer Stem Cells • Reformulation of failed chemotherapeutic drugs • 3D tumor microenvironment Tissue Culture Systems • Single cell Proteomic Analysis from solid tumors •Phospho-Threonine Protein Standards • Biosensor-based tumor Biopsy Device • Radiation Modulators • Software Tools for environmental measures 372 Projects
Na#onal Ins#tutes of Health (NIH) SBIR/STTR Programs Na#onal Ins#tute on Alcohol Abuse and Alcoholism • POC/Title and or Ins#tute/Website: Kathy Jung, Ph.D., /Program Director. h6p://www.niaaa.nih.gov/ Email: email@example.com. • Mission/interest – The mission of NIAAA is to direct, support, and conduct biomedical and behavioral research on the causes, consequences, treatment, and prevenIon of alcoholism and alcohol-‐related problems, including health consequences. • Uniqueness – The majority of our awards are invesIgator-‐iniIated. • Budget -‐ Annual SBIR + STTR budget ~$11 M (FY14). • Topics – Listed in the Omnibus solicitaIon; also invesIgator-‐iniIated research. • Awards (Amount and Dollar Range Phase I: up to $225K each; Phase II: up to 1.5M each. 25-‐30 new and conInuing awards per year. • Grants vs Contracts -‐ Variable. Currently 90% grants, 10% contracts. • Solicita#ons (Open/Close Omnibus and most solicitaIons; April 5th; August 5th; December 5th; for AIDS (May 7th; September 7th; January 7th). • Commercializa#on Assistance -‐ NIH oﬀers the Phase I Niche Assessment Program and Phase II CommercializaIon Assistance Program annually for SBIR and STTR awardees.
Na#onal Ins#tutes of Health (NIH) SBIR/STTR Programs • POC and Ins#tute Website: Chris&ne Densmore, M.S., NIDDK SBIR/STTR Coordinator and Program Director h>p://www.niddk.nih.gov. • Mission – The SBIR/STTR programs are vehicles of innova&on for development and commercializa&on of novel technologies and products to advance science and disseminate science-‐based informa&on on diabetes and other endocrine and metabolic diseases; diges&ve diseases, nutri&onal disorders, and obesity; and kidney, urologic, and hematologic diseases, to improve people’s health and quality of life. • Uniqueness -‐ NIDDK SBIR/STTRs support technology development from basic through clinical studies/ trials. The majority of applica&ons are for inves&gator-‐ini&ated projects. • Budget $48M (FY14). • Topics – The majority of applica&ons are inves&gator-‐ini&ated via the Omnibus SBIR/STTR solicita&ons (PA-‐14-‐071/72). DK has a number of FOAs targeted toward speciﬁc-‐mission areas as well (see link above). • Awards -‐ Phase I up to $225K (generally 1yr), Phase II up to 1.5M (generally 2yrs), Phase IIB • up to 3M (up to 3yrs). • Grants vs Contracts – Grants. • Solicita#ons (Open/Close) – Applica&ons are due April 5th; August 5th; December 5th. • Commercializa#on Assistance -‐ NIH Phase I Niche Assessment Program and Phase II Commercializa&on Assistance Program.
Na#onal Ins#tute of Mental Health (NIMH) SBIR/ STTR Programs • POC/Title and or Ins#tute/Website: – Margaret Grabb, Ph.D., Coordinator -‐ SBIR/STTR. (h
DHHS,Na'onal Ins'tutes of Health (NIH) SBIR/STTR Programs Na'onal Ins'tute on Minority Health and Health Dispari'es (NIMHD) • POC/Title and or Ins2tute/Website: Vincent A. Thomas, Jr., M.S.W., M.P.A.,SBIR/STTR Program Manager & Derrick C. Tabor, Ph.D., Program Oﬃcial; hPp://www.nimhd.nih.gov • Mission/interest-‐ The mission of NIMHD is to lead scien'ﬁc research to improve minority health and eliminate health dispari'es. • Uniqueness-‐ NIMHD SBIR/STTR funding opportuni'es are intended to assist small business concerns (SBCs) to develop and commercialize innova've technologies that improve minority health and reduce health dispari'es by providing a product, process or service that is eﬀec've, aﬀordable, culturally acceptable, and deliverable to racial/ethnic minori'es, low-‐income and rural popula'ons. • Budget-‐ Annual SBIR + STTR budget ~$8.1M • Areas of Interest-‐ Improving health outcomes and achieving health equity for health disparity popula'ons; innova've health dispari'es research and use of electronic health records, and the development of innova've so]ware and tools for science and health science educa'on. Interven'ons that address: Behavioral change, Preven'on, Social determinants of Health and Health Literacy. • Awards (Amt. and Dollar Range Phase l's up to $1SOK to $225K each applica'on, and Phase ll's up to $1M to 1.5M each applica'on. • Contract vs Grant-‐ Grants • PHS 2014-‐2, Omnibus Solicita2on (Receipt Dates)-‐ April 5, August 5, December 5 • Commercializa2on Assistance-‐ The NIH provides two programs: the Niche Assessment Program for Phase I awardees helps the SBC to iden'fy other uses of technology, determines compe''ve advantages and develops market entry strategy; and the Commercializa'on Assistance Program for Phase II awardees helps promising small life science companies develop their commercial businesses and transi'on their SBIR/STTR-‐ developed technologies into the marketplace.
Na#onal Ins#tutes of Health (NIH) SBIR/STTR Programs Na#onal Center for Advancing Transla#onal Sciences (NCATS) • POC/Title and or Ins#tute/Website: Lili M. Por#lla, MPA NCATS SBIR/STTR Program Director h7p://www.ncats.nih.gov/funding-‐and-‐noCces/sma ll-‐business/small-‐business.html • Mission/interest – In 2011, NCATS was established to transform the translaConal science process so that new treatments and cures for disease can be delivered to paCents faster. TranslaConal sciences comprise the process of turning observaCons in the laboratory and clinic into eﬀecCve intervenCons that improve the health of individuals and the public — from diagnosCcs and therapeuCcs to medical procedures and behavioral changes. • Uniqueness -‐ NCATS is interested in the development of innovaCve tools, technologies and intervenCon plaMorms that would support the creaCon of novel therapeuCcs or diagnosCcs, especially for rare and neglected diseases. The applicaCon may address any stage of translaCon. • Budget -‐ Annual SBIR + STTR budget ~$16M (FY14). • Topics -‐ hNp://www.ncats.nih.gov/funding-‐and-‐no#ces/sma ll-‐business/topics/topics.html • Awards (Amount and Dollar Range ~15 Phase I’s up to $225K each and ~ 15 Phase II’s /year range up to 1.5M each. • Grants vs Contracts -‐ 75% grants, 25% contracts. • Solicita#ons (Open/Close Omnibus and most solicitaCons; April 5th; August 5th; December 5th • Commercializa#on Assistance -‐ NIH oﬀers the Phase I Niche Assessment Program and Phase II CommercializaCon Assistance Program annually for SBIR and STTR awardees. NCATS has several preclinical programs such as TRND and BrIDGs.
Na#onal Ins#tutes of Health SBIR/STTR Programs Na#onal Eye Ins#tute (NEI) • Contact Person: Jerome R. Wujek, Ph.D., NEI SBIR/STTR Program Director, Email: firstname.lastname@example.org; Ins#tute Website: hDp://www.nei.nih.gov/. • Mission/interest – The mission of NEI is to reduce the burden of blinding eye diseases and visual disorders, and to preserve sight. ApplicaLons for all areas of vision research are encouraged. • Uniqueness -‐ NEI supports predominantly invesLgator-‐iniLated research, meaning very few targeted programs. • Budget -‐ Annual SBIR + STTR budget ~$17M (FY14). • Topics – Please see Program DescripLons and Research Topics linked to 2014 Omnibus Grant SolicitaLons of the NIH (found at hDp://grants.nih.gov/grants/funding/sbir.htm). • Awards -‐ Standard published budget guideline for NIH. • Grants vs Contracts – Grants. • Solicita#ons (Open/Close) – Standard receipt dates (April 5th; August 5th; December 5th). • Commercializa#on Assistance – As available through NIH.
1 National Institute of Allergy and Infectious Diseases (NIAID), NIH POC/Title and or Institute/Website: Natalia Kruchinin Ph.D., NIAID,NIH SBIR/STTR Program Coordinator email: email@example.com http://www.niaid.nih.gov/researchfunding/sb/Pages/ default.aspx Mission/interest: National Institute of Allergy and Infectious Diseases, NIH conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. Budget - Annual SBIR + STTR budget ~$118M (FY14) Topics- Development of therapies, vaccines, diagnostic tests and other technologies for diseases in NIAID mission areas in order to improve human health. NIAID Small Business High Priority Areas of Interest: http://www.niaid.nih.gov/researchfunding/sb/pages/ sbirareas.aspx Awards (Amount and Dollar Range)- Phase I:$225,000; Phase II $1.5M Grants vs. Contracts - 92% grants, 8% contracts. Solicitations (Open/Close) -Omnibus and most solicitations; April 5th; August 5th; December 5th; for AIDS (May 7th; September 7th; January 7th). More than 10 open solicitations, some with custom dates.
Pages you may also like
You can also read